Nucleolar protein p120 expression in oral carcinoma

Anticancer Research

Volumn 19, Issue 2 B, 1999, Pages 1423-1426

  Ventura, L ^a   Migaldi, M ^b   Criscuolo, M ^b   Castelli, M ^c   Barbolini, G ^a   Ranieri, A ^a   Bifaretti, G ^a   Uboldi, P ^a   Leocata, Pietro ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell proliferation; Immunohistochemistry; Oral cancer; p129 nucleolar protein; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY; NUCLEOLAR PROTEIN P120; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER STAGING; CELL CYCLE G1 PHASE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING; NUCLEAR PROTEINS; PLOIDIES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033034716     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Freeman JW, Busch RK, Gyorkey F, Gyorkey P, Ross BE, Busch H: Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. Cancer Res 48: 1244-1251, 1988.
2. Freeman JW, Haziewood JE, Bondada V, Cibull ML, Fonagy A, Ochs R, Busch RK, Busch H: Proliferation related nucleolar antigens p145 and p120 associated with separate nucleolar elements and differences in tissue distribution. Cancer Commun 6: 367-372, 1989.
3. Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK, Busch H: Prognostic significance of proliferation associated nucleolar antigen p120 in human breast carcinoma. Cancer Res 51: 1973-1978, 1991.
4. McGrath P, Holley DT, Hamby LS, Powell DE, Mattingly CA, Freeman JW: Prospective study correlating p120 antigen expression with established prognostic factors in breast cancer. Surg Oncol 3: 69-77, 1994.
5. McGrath P, Holley DT, Hamby LS, Powell DE, Mattingly CA, Freeman JW: Proliferation-associated nucleolar antigen p120: a prognostic marker in node-negative breast cancer. Surgery 116: 616-620, 1994.
6. Bocker T, Bittinger A, Wieland W, Buetter R, Fauser G, Hofstaedter F, Rüschoff J: In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Mod Pathol 3: 226-231, 1995.
7. Migaldi M, Barbolini G, Trerè D, Criscuolo M, Martinelli AM, Zunarelli E: Immunohistochemical detection of nucleolar protein p120 in paraffin embedded tissues. Histochem J 29: 661-668, 1997.
8. Migaldi M, Criscuolo M, Zunarelli E, Lo Bianco L, Martinelli AM, Barbolini G: p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 189-196, 1998.
9. Kokal WA, Gardiner RL, Sheibani K, Zak IW, Beatty JD, Riihimaki DU, Wagman LD, Terz JJ: Tumour DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region. Am J Surg 156: 276-280, 1988.
10. th edition. New York, Wiley-Liss, 1997.
11. Nucleoli of tumor cells. In: Busch H, Smetana K, eds. The nucleolus. New York, Academic Press: 448-471, 1970
12. Kobayashi I, Matsuo K, Ozeki S, Ohishi M. Ishibashi Y, Sakai H: The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining. Hum Pathol 26: 907-913, 1995.
13. Bifaretti G, Giannoni M, Anselmi MF: Valutazione delle NOR nell'epitelio normale, nella leucoplachia e nel cancro della bocca. IV Congresso Nazionale del Collegio dei Docenti di Odontoiatria, Roma, 16-19 Aprile 1997, II: 1469-1474.
14. Treré D, Montanaro L, Migaldi M, Pession A, Derenzini M: Relationship between p120 antigen expression and cell proliferative rate in cancer cells. Personal communication.
15. Kearsley JH, Bryson G, Battistutta D, Collins RJ: Prognostic importance of cellular DNA content in head-and-neck squamous-cell cancers. A comparison of retrospective and prospective series. Int J Cancer 47: 31-37, 1991.
16. Ensley JF, Maciorowski Z: Clinical application of DNA content parameter in patients with squamous cell carcinomas of the head and neck. Semin Oncol 21: 330-339, 1994.
17. Ochs RL, Reilly MT, Freeman JW, Busch H: Intranucleolar localization of human proliferating cell nucleolar antigen p120. Cancer Res 48: 6523-6529, 1988.
18. Fonagy A, Swiderski C, Freeman JW: Altered transcription control is responsible for the increased level of proliferation-associated P120 in rapidly growing breast carcinoma. Int J Cancer 60: 407-412, 1995.
19. Fonagy A, Swiderski C, Freeman JW: Nucleolar p120 is expressed as a delayed early response gene and is inducible by DNA-damaging agents. J Cell Physiol 164: 634-643, 1995.
20. Blagosklonny MV, Iglesias A, Zhan Z, Fojo T: Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs. Biochem Biophys Res Commun 244: 368-373, 1998.
21. Fonagy A, Swiderski C, Ostrovsky AM, Bolton WE, Freeman JW: Effect of nucleolar P120 expression level on the proliferation capacity of breast cancer cells. Cancer Res 54: 1859-1864, 1994.
22. Hart IR, Saini A: Biology of tumor metastasis. Lancet 339: 1453-1457, 1992.